Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
12.72
+0.06 (0.48%)
Jan 14, 2026, 1:36 PM EST - Market open
Embecta Market Cap
Embecta has a market cap or net worth of $753.24 million as of January 14, 2026. Its market cap has decreased by -37.79% in one year.
Market Cap
753.24M
Enterprise Value
1.98B
1-Year Change
-37.79%
Ranking
Category
Stock Price
$12.72
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $753.24M, a decrease of -71.85%. That is a compound annual growth rate of -28.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 749.62M | 6.57% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |